Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (808)	7/1/2003 12:28:41 AM
From: tuck	Read Replies (2) \| Respond to of 1005

Elephants in CALP today, and to a lesser extent (because its average volume has been higher) EXEL. I didn't see news for either one. Wonder what's coming down the pike for those two . . . Also TWTI, which has been on the comeback trail of late. Giving some back today. Haven't been paying attention to it recently. AMEV with respectable volume, too. That one remains high on my buy list should we get the summer biotech (perhaps general market) doldrums that I'm expecting. Anyone have other suggestions for purchasing on weakness? End of month adjustments accounting for the volume? Cheers, Tuck